Sarcopenia: The new definitions

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 1, 2015, Pages 1-4

  Cederholm, Tommy ^a,b   Morley, John E ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FRAIL; Frailty syndrome; Muscle power; SARC F; Sarcopenia; Skeletal mass; The European working group on sarcopenia in older persons

Indexed keywords

TESTOSTERONE; VITAMIN D;

AEROBIC EXERCISE; GRIP STRENGTH; HUMAN; LOW DRUG DOSE; MUSCLE FUNCTION; MUSCLE MASS; PROTEIN INTAKE; RESISTANCE TRAINING; REVIEW; SARCOPENIA; WALKING SPEED; GAIT; MUSCLE STRENGTH; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

GAIT; HUMANS; MUSCLE STRENGTH; MUSCLE, SKELETAL; SARCOPENIA;

EID: 84916623719     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000119     Document Type: Review

References (46)

1. Morley JE. Editorial: Frailty screening comes of age. J Nutr Health Aging 2014; 18: 453-454.
2. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013; 14: 392-397.
3. Michel JP. Sarcopenia: There is a need for some steps forward. J Am Med Dir Assoc 2014; 15: 379-380.
4. Clark BC, Manini TM. What is dynapenia? Nutrition 2012; 28: 495-503.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
6. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-256.
7. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011; 12: 403-409.
8. Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101.
9. Dam T-T, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Geront A Biol Sci Med Sci 2014; 69: 584-590.
10. Kim YP, Kim S, John JY, Hwang HS. Effect of interaction between dynapenic component of the European working group on sarcopenia in older people sarcopenia criteria and obesity on activities of daily living in the elderly. J Am Med Dir Assoc 2014; 15: 371.e1-e5.
11. Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc 2013; 14: 911-915.
12. Valpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: Application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014; 69: 438-446.
13. Vetrano DL, Landi F, Volpato S, et al. Association of sarcopenia with shortand long-term mortality in older adults admitted to acute care wards: Results from the CRIME study. J Gerontol A Biol Sci Med Sci 2014; 69: 1154-1161.
14. Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: Findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013; 42: 378-384.
15. Lee WJ, Liu LK, Peng LN, et al., ILAS Research Group. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 2013; 14: 528.e1-e7.
16. DaSilva Alexandre T, de Oliveira Duarte YA, Ferreira Santos JL, et al. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging 2014; 18: 547-553.
17. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012; 13: 121-126.
18. Malmstrom TK, Miller DK, Herning MM, Morley JE. Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middleaged African Americans. J Cachexia Sarcopenia Muscle 2013; 4: 179-186.
19. Landi F, Onder G, Bernabei R. Sarcopenia and diabetes: Two sides of the same coin. J Am Med Dir Assoc 2013; 14: 540-541.
20. Leenders M, Verdijk LB, van der Hoeven L, et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14: 585-592.
21. Barbat-Artigas S, Rolland Y, Vellas B, Aubertin-Leheudre M. Muscle quantity is not synonymous withmusclequality. JAmMed Dir Assoc2013;14: 852.e1-e7.
22. Barbat-Artigas S, Pion CH, Leduc-Gaudet JP, et al. Exploring the role of muscle mass, obesity, and age in the relationship between muscle quality and physical function. J Am Med Dir Assoc 2014; 15: 303.e13-e20.
23. Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The PIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 2009; 89: 1895-1900.
24. Ravindrarajah R, Lee DM, Pye SR, et al., European Male Aging Study Group. The ability of three different models of frailty to predict all-cause mortality: Results from the European Male Aging study (EMAS). Arch Gerontol Geriatr 2013; 57: 360-368.
25. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012; 16: 601-608.
26. Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012; 60: 1478-1486.
27. Evans CJ, Chiou CF, Fitzgerald KA, et al. Development of a newpatient-reported outcome measure in sarcopenia. J Am Med Dir Assoc 2011; 12: 226-233.
28. Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013; 14: 531-532.
29. Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014; 15: 630-634.
30. Cao L, Chen S, Zou C, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 2014; 18: 277-283.
31. Malmstrom TK, Miller DK, Morley JE, et al. A comparison of four frailty models. J Am Geriatr Soc 2014; 62: 721-726.
32. Sakuma K, Aoi W, Yamaguchi A. Current understanding of sarcopenia: Possible candidates modulating muscle mass. Pflugers Arch 2014. [Epub ahead of print
33. Morley JE. Sarcopenia in the elderly. Fam Pract 2012; 29 (Suppl 1): I44-i48.
34. Rolland Y, Onder G, Morley JE, et al. Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 2011; 27: 423-447.
35. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 2013; 14: 877-882.
36. Drey M, Krieger B, Sieber CC, et al. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 2014; 15: 435-439.
37. Matthieu-Costello O, Kong A, Ciaraldi TP, et al. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: Relationship to glucose disposal. Metabolism 2003; 52: 540-546.
38. Carlsson M, Littbrand H, Gustafson Y, et al. Effects of high-intensity exercise and protein supplement on muscle mass in ADL dependent older people with and without malnutrition: A randomized controlled trial. J Nutr Health Aging 2011; 15: 554-560.
39. Singh NA, Quine S, Clemson LM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012; 13: 24-30.
40. Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: A systematic review. J Am Med Dir Assoc 2012; 13: 418-428.
41. Pahor M, Guralnik JM, Ambrosius WT, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: The LIFE Study randomized clinical trial. JAMA 2014; 311: 2387-2396.
42. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14: 542-559.
43. Pedersen AN, Cederholm T. Health effects of protein intake in healthy elderly populations: A systematic literature review. Food Nutr Res 2014; 58.: . doi: 10.3402/fnr.v58.23364; e-Collection 2014.
44. Deutz NE, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clin Nutr 2014. [Epub ahead of print
45. Chapman IM, Visvanathan R, Hammond AJ, et al. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009; 89: 880-889.
46. Rolland Y, de Souto Barreto P, Abellan Van Kan G, et al., French Group of Geriatrics and Nutrition. Vitamin D supplementation in older adults: Searching for specific guidelines in nursing homes. J Nutr Health Aging 2013; 17: 402-412.